Abstract:BackgroundThe primary issue arising from prostate cancer (PCa) is its high prevalence to metastasize to bone, which severely affects the quality of life and survival time of PCa patients. miR-210-3p is a well-documented oncogenic miRNA implicated in various aspects of cancer development, progression and metastasis. However, the clinical significance and biological roles of miR-210-3p in PCa bone metastasis remain obscure.MethodsmiR-210-3p expression was evaluated by real-time PCR in 68 bone metastatic and 81 non-bone metastatic PCa tissues. The biological roles of miR-210-3p in the bone metastasis of PCa were investigated both in vitro by EMT and Transwell assays, and in vivo using a mouse model of left cardiac ventricle inoculation. Bioinformatics analysis, real-time PCR, western blot and luciferase reporter analysis were applied to discern and examine the relationship between miR-210-3p and its potential targets. RT-PCR was performed to identify the underlying mechanism of miR-210-3p overexpression in bone metastasis of PCa. Clinical correlation of miR-210-3p with its targets was examined in human PCa and metastatic bone tissues.ResultsmiR-210-3p expression is elevated in bone metastatic PCa tissues compared with non-bone metastatic PCa tissues. Overexpression of miR-210-3p positively correlates with serum PSA levels, Gleason grade and bone metastasis status in PCa patients. Upregulating miR-210-3p enhances, while silencing miR-210-3p represses the EMT, invasion and migration of PCa cells in vitro. Importantly, silencing miR-210-3p significantly inhibits bone metastasis of PC-3 cells in vivo. Our results further demonstrate that miR-210-3p maintains the sustained activation of NF-κB signaling via targeting negative regulators of NF-κB signaling (TNF-α Induced Protein 3 Interacting Protein 1) TNIP1 and (Suppressor Of Cytokine Signaling 1) SOCS1, resulting in EMT, invasion, migration and bone metastasis of PCa cells. Moreover, our results further indicate that recurrent gains (amplification) contribute to miR-210-3p overexpression in a small number of PCa patients. The clinical correlation of miR-210-3p with SOCS1, TNIP1 and NF-κB signaling activity is verified in PCa tissues.ConclusionOur findings unravel a novel mechanism for constitutive activation of NF-κB signaling pathway in the bone metastasis of PCa, supporting a functional and clinical significance of epigenetic events in bone metastasis of PCa.

The TGF- β signalling negative regulator PICK1 represses prostate cancer metastasis to bone

PICK1 Promotes Caveolin-Dependent Degradation of TGF-β Type I Receptor

Protein Interacting with C Α Kinase 1 (PICK1) is Involved in Promoting Tumor Growth and Correlates with Poor Prognosis of Human Breast Cancer

Loss of TGF-β Signaling in Osteoblasts Increases Basic-Fgf and Promotes Prostate Cancer Bone Metastasis.

TGF- signaling regulates <i>SPOP</i> expression and promotes prostate cancer cell stemness

miR-615-3p promotes the epithelial-mesenchymal transition and metastasis of breast cancer by targeting PICK1/TGFBRI axis

Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway

SERPINH1 Modulates Apoptosis by Inhibiting P62 Ubiquitination Degradation to Promote Bone Metastasis of Prostate Cancer

Parathyroid Hormone-Related Protein Inhibits DKK1 Expression Through C-Jun-mediated Inhibition of Β-Catenin Activation of the DKK1 Promoter in Prostate Cancer

PICK1 inhibits the malignancy of nasopharyngeal carcinoma and serves as a novel prognostic marker

Effects of Dickkopf-1 (DKK-1) on Prostate Cancer Growth and Bone Metastasis

Assessing the Potential Prognostic and Immunological Role of TK1 in Prostate Cancer

TGF-β1 Promotes Epithelial-to-mesenchymal Transition and Stemness of Prostate Cancer Cells by Inducing PCBP1 Degradation and Alternative Splicing of CD44

STK10 Knockout Inhibits Cell Migration and Promotes Cell Proliferation Via Modulating the Activity of ERM and P38 MAPK in Prostate Cancer Cells.

PCMT1 Regulates the Migration, Invasion, and Apoptosis of Prostate Cancer Through Modulating the PI3K/AKT/GSK-313 Pathway

Transcriptional downregulation of miR-127-3p by CTCF promotes prostate cancer bone metastasis by targeting PSMB5.

SP1 Initiates Epithelial-Mesenchymal Transition of CTCs and Inhibits Metastasis in Prostate Cancer

FZD8, a target of p53, promotes bone metastasis in prostate cancer by activating canonical Wnt/β-catenin signaling

Tgfbr2 inactivation facilitates cellular plasticity and development of Pten-null prostate cancer

Transcription factor p53-mediated activation of miR-519d-3p and downregulation of E2F1 attenuates prostate cancer growth and metastasis

Wild-Type P53 Suppresses The Epithelial-Mesenchymal Transition And Sternness In Pc-3 Prostate Cancer Cells By Modulating Mir-145